Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
Ogasa, Masaaki, Kimura, Tatsuya, Nakamura, Mitsutaka, Guarino, John
Published in Psychopharmacology (01.02.2013)
Published in Psychopharmacology (01.02.2013)
Get full text
Journal Article
Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
Meltzer, Herbert Y, Cucchiaro, Josephine, Silva, Robert, Ogasa, Masaaki, Phillips, Debra, Xu, Jane, Kalali, Amir H, Schweizer, Edward, Pikalov, Andrei, Loebel, Antony
Published in American Journal of Psychiatry (01.09.2011)
Published in American Journal of Psychiatry (01.09.2011)
Get full text
Journal Article
Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone
Harvey, Philip D, Ogasa, Masaaki, Cucchiaro, Josephine, Loebel, Antony, Keefe, Richard S.E
Published in Schizophrenia research (01.04.2011)
Published in Schizophrenia research (01.04.2011)
Get full text
Journal Article
Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial
Nakamura, Mitsutaka, Ogasa, Masaaki, Guarino, John, Phillips, Debra, Severs, Joseph, Cucchiaro, Josephine, Loebel, Antony
Published in The journal of clinical psychiatry (01.06.2009)
Published in The journal of clinical psychiatry (01.06.2009)
Get more information
Journal Article
Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity
Ishibashi, Tadashi, Horisawa, Tomoko, Tokuda, Kumiko, Ishiyama, Takeo, Ogasa, Masaaki, Tagashira, Rie, Matsumoto, Kenji, Nishikawa, Hiroyuki, Ueda, Yoko, Toma, Satoko, Oki, Hitomi, Tanno, Norihiko, Saji, Ikutaro, Ito, Akira, Ohno, Yukihiro, Nakamura, Mitsutaka
Published in The Journal of pharmacology and experimental therapeutics (01.07.2010)
Published in The Journal of pharmacology and experimental therapeutics (01.07.2010)
Get full text
Journal Article
Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
Potkin, Steven G, Ogasa, Masaaki, Cucchiaro, Josephine, Loebel, Antony
Published in Schizophrenia research (01.11.2011)
Published in Schizophrenia research (01.11.2011)
Get full text
Journal Article
Poster #197 LONG-TERM TREATMENT WITH LURASIDONE IN SCHIZOPHRENIA: RESULTS OF AN 8-WEEK DOUBLE-BLIND ACUTE STUDY FOLLOWED BY A 44-WEEK OPEN-LABEL EXTENSION
Kato, Masaki, Ogasa, Masaaki, Ogo, Hiroki, Ishige, Yoko, Sawabe, Hiroshi, Siu, Cynthia, Loebel, Antony
Published in Schizophrenia research (01.04.2012)
Published in Schizophrenia research (01.04.2012)
Get full text
Journal Article
A THREE ARM DOSE FINDING STUDY OF LURASIDONE: EFFICACY AND TOLERABILITY DATA
Harvey, Philip D, Murasaki, Mitsukuni, Cucchiaro, Josephine, Ogasa, Masaaki, Loebel, Antony
Published in Schizophrenia research (01.04.2010)
Published in Schizophrenia research (01.04.2010)
Get full text
Journal Article
LURASIDONE IN THE TREATMENT OF ACUTE SCHIZOPHRENIA: RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED PEARL 2 TRIAL
Cucchiaro, Josephine, Silva, Robert, Ogasa, Masaaki, Xu, Jane, Phillips, Debra, Simonelli, Doreen, Kalali, Amir, Loebel, Antony, Meltzer, Herbert
Published in Schizophrenia research (01.04.2010)
Published in Schizophrenia research (01.04.2010)
Get full text
Journal Article
Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT 7 ) and 5-HT 1A Receptor Activity
Ishibashi, Tadashi, Horisawa, Tomoko, Tokuda, Kumiko, Ishiyama, Takeo, Ogasa, Masaaki, Tagashira, Rie, Matsumoto, Kenji, Nishikawa, Hiroyuki, Ueda, Yoko, Toma, Satoko, Oki, Hitomi, Tanno, Norihiko, Saji, Ikutaro, Ito, Akira, Ohno, Yukihiro, Nakamura, Mitsutaka
Published in The Journal of pharmacology and experimental therapeutics (01.07.2010)
Published in The Journal of pharmacology and experimental therapeutics (01.07.2010)
Get full text
Journal Article